• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Diagnostic nomogram based on ultrasound and clinical data of predicting malignant lymph nodes in HIV patients with lymphadenopathy.

作者信息

Pan Lin, Yang Chaoting, Shao Huaguo

机构信息

Department of Ultrasound, Hangzhou Xixi Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.

The Fourth Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.

出版信息

Front Cell Infect Microbiol. 2025 Sep 8;15:1622903. doi: 10.3389/fcimb.2025.1622903. eCollection 2025.

DOI:10.3389/fcimb.2025.1622903
PMID:40989183
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12450984/
Abstract

BACKGROUND AND AIMS

Acquired Immune Deficiency Syndrome (AIDS), caused by Human Immunodeficiency Virus (HIV), leads to severe immunodeficiency, making patients susceptible to opportunistic infections and malignancies. Lymphadenopathy is a common symptom in AIDS patients, reflecting immune system responses but also indicating potential disease progression. Distinguishing between benign and malignant lymphadenopathy is crucial for appropriate treatment. This study aimed to develop a diagnostic method for differentiating benign and malignant lymph nodes in HIV-infected patients using clinical and ultrasound data.

METHODS

The study was conducted at Hangzhou Xixi Hospital from March 2016 to March 2024, including 149 HIV patients with confirmed lymphadenopathy. Ultrasound examinations were performed to assess lymph node characteristics, and biopsies were conducted for pathological confirmation. Statistical analysis involved the least absolute shrinkage and selection operator (LASSO) regression to identify significant predictors and construct a nomogram for predicting lymph node malignancy.

RESULTS

The malignant lymph nodes had larger short and long diameters, and differences in shape, echogenicity, and hilum compared to benign lymph nodes. Lymphocyte count and T cell subsets were higher in malignant lymph nodes. The LASSO regression model identified short diameter, lymphocyte ratio, CD3 T cell count, and CD4 T cell ratio as significant predictors. The nomogram constructed based on these features demonstrated good predictive accuracy (AUC = 0.904).

CONCLUSIONS

In conclusion, our study developed a diagnostic nomogram based on clinical and ultrasound data to differentiate benign and malignant lymph nodes in HIV patients. This tool had diagnostic accuracy and offers practical guidance for clinical management of HIV patients with lymphadenopathy.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24c5/12450984/5f346862c622/fcimb-15-1622903-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24c5/12450984/fb02dc546006/fcimb-15-1622903-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24c5/12450984/908ffe0d4fbd/fcimb-15-1622903-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24c5/12450984/5f346862c622/fcimb-15-1622903-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24c5/12450984/fb02dc546006/fcimb-15-1622903-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24c5/12450984/908ffe0d4fbd/fcimb-15-1622903-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24c5/12450984/5f346862c622/fcimb-15-1622903-g003.jpg

相似文献

1
Diagnostic nomogram based on ultrasound and clinical data of predicting malignant lymph nodes in HIV patients with lymphadenopathy.
Front Cell Infect Microbiol. 2025 Sep 8;15:1622903. doi: 10.3389/fcimb.2025.1622903. eCollection 2025.
2
Clinical benefits of deep learning-assisted ultrasound in predicting lymph node metastasis in pancreatic cancer patients.深度学习辅助超声在预测胰腺癌患者淋巴结转移中的临床益处
Future Oncol. 2025 Jun 23:1-11. doi: 10.1080/14796694.2025.2520149.
3
Vesicoureteral Reflux膀胱输尿管反流
4
Postoperative nomogram for predicting involved lymph node in differentiated thyroid carcinoma: an observational study.用于预测分化型甲状腺癌淋巴结受累情况的术后列线图:一项观察性研究
Future Oncol. 2025 Sep;21(21):2785-2793. doi: 10.1080/14796694.2025.2543233. Epub 2025 Aug 9.
5
Developing and Evaluating a Nomogram Model Predicting Axillary Lymph Node Metastasis of Triple-Negative Breast Cancer Based on Multimodal Imaging Characteristics.基于多模态影像特征建立并评估预测三阴性乳腺癌腋窝淋巴结转移的列线图模型
Acad Radiol. 2025 Aug;32(8):4382-4394. doi: 10.1016/j.acra.2025.04.031. Epub 2025 May 15.
6
Value of a BRAF and lymphocyte subset-based nomogram for discriminating benign lesions from papillary thyroid carcinoma in C-TIRADS 3 and higher nodules.基于BRAF和淋巴细胞亚群的列线图在鉴别C-TIRADS 3类及以上结节中的甲状腺乳头状癌与良性病变方面的价值。
Front Endocrinol (Lausanne). 2025 Aug 15;16:1608222. doi: 10.3389/fendo.2025.1608222. eCollection 2025.
7
The value of ultrasonographic scoring method and nomogram in assessing cervical lymph node metastasis of papillary thyroid carcinoma.超声评分法和列线图在评估甲状腺乳头状癌颈部淋巴结转移中的价值。
Thyroid Res. 2025 Jul 22;18(1):36. doi: 10.1186/s13044-025-00255-6.
8
Development and Validation of an Ultrasound and Clinicopathological Features-Based Nomogram for Predicting Non-Sentinel Lymph Node Metastasis in Breast Cancer Patients: A Single-Center Observational Study.基于超声和临床病理特征的列线图预测乳腺癌患者非前哨淋巴结转移的开发与验证:一项单中心观察性研究
J Clin Ultrasound. 2025 Jun;53(5):975-988. doi: 10.1002/jcu.23960. Epub 2025 Mar 17.
9
A Validated Ultrasound-Based Scoring System to Stratify Risk of Axillary Metastasis in Breast Cancer: AX-RADS (Axillary Imaging Reporting and Data System).一种经过验证的基于超声的乳腺癌腋窝转移风险分层评分系统:AX-RADS(腋窝影像报告和数据系统)。
J Surg Oncol. 2025 Jul;132(1):28-34. doi: 10.1002/jso.28159. Epub 2025 May 20.
10
Shoulder Arthrogram肩关节造影

本文引用的文献

1
The Usefulness of Mediastinal Cryobiopsy in the Diagnosis of Mediastinal Lymphadenopathy in HIV Patients.纵隔冷冻活检在HIV患者纵隔淋巴结病诊断中的应用价值
HIV AIDS (Auckl). 2025 Jun 7;17:135-141. doi: 10.2147/HIV.S499971. eCollection 2025.
2
HIV-associated cancers and lymphoproliferative disorders caused by Kaposi sarcoma herpesvirus and Epstein-Barr virus.人类免疫缺陷病毒相关癌症和卡波西肉瘤疱疹病毒与 Epstein-Barr 病毒引起的淋巴组织增生性疾病。
Clin Microbiol Rev. 2024 Sep 12;37(3):e0002223. doi: 10.1128/cmr.00022-23. Epub 2024 Jun 20.
3
HIV/AIDS in Indonesia: current treatment landscape, future therapeutic horizons, and herbal approaches.
印度尼西亚的艾滋病毒/艾滋病:当前的治疗现状、未来的治疗前景和草药方法。
Front Public Health. 2024 Feb 14;12:1298297. doi: 10.3389/fpubh.2024.1298297. eCollection 2024.
4
Focused investigations to expedite cancer diagnosis among patients with lymphadenopathy in a tuberculosis and HIV-endemic region.在结核病和艾滋病流行地区,对淋巴结病患者进行集中调查以加快癌症诊断。
AIDS. 2023 Mar 15;37(4):587-594. doi: 10.1097/QAD.0000000000003456. Epub 2022 Dec 6.
5
Preoperative ultrasound combined with routine blood tests in predicting the malignant risk of pancreatic cystic neoplasms.术前超声联合常规血液检查对预测胰腺囊性肿瘤恶性风险的价值。
Cancer Biol Med. 2022 Nov 1;19(10):1503-16. doi: 10.20892/j.issn.2095-3941.2022.0258.
6
Antiretroviral drug exposure in lymph nodes is heterogeneous and drug dependent.抗逆转录病毒药物在淋巴结中的暴露是不均匀的,且依赖于药物。
J Int AIDS Soc. 2022 Apr;25(4):e25895. doi: 10.1002/jia2.25895.
7
Persistent HIV transcription and variable antiretroviral drug penetration in lymph nodes during plasma viral suppression.在血浆病毒抑制期间,淋巴结中持续的 HIV 转录和可变的抗逆转录病毒药物渗透。
AIDS. 2022 Jun 1;36(7):985-990. doi: 10.1097/QAD.0000000000003201. Epub 2022 Feb 18.
8
HIV persistence in lymph nodes.HIV 在淋巴结中的持续存在。
Curr Opin HIV AIDS. 2021 Jul 1;16(4):209-214. doi: 10.1097/COH.0000000000000686.
9
Pathogenesis of HIV-Related Lung Disease: Immunity, Infection, and Inflammation.HIV 相关肺部疾病的发病机制:免疫、感染和炎症。
Physiol Rev. 2020 Apr 1;100(2):603-632. doi: 10.1152/physrev.00039.2018. Epub 2019 Oct 10.
10
Predicting Benign Prostate Pathology on Magnetic Resonance Imaging/Ultrasound Fusion Biopsy in Men with a Prior Negative 12-core Systematic Biopsy: External Validation of a Prognostic Nomogram.在有先前阴性 12 针系统活检史的男性中,基于磁共振成像/超声融合活检预测良性前列腺病变:预后列线图的外部验证。
Eur Urol Focus. 2019 Sep;5(5):815-822. doi: 10.1016/j.euf.2018.05.005. Epub 2018 May 23.